We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA OPENS NEW FRONT IN BATTLE OVER AUTHORIZED GENERICS
GPhA OPENS NEW FRONT IN BATTLE OVER AUTHORIZED GENERICS
October 1, 2004
The Generic Pharmaceutical Association (GPhA) is asserting brand drugmakers reap huge financial windfalls as the result of competing best-price reporting requirements used by the FDA and the Centers for Medicare & Medicaid Services.